STOM and breast carcinoma: In contrast, in breast cancer, the expression of stomatin in these cells was 31 % (7/23) negative, 39 % weak (9/23), 26 % moderate (6/23), and 4 % (1/23) strong positive when tissue microarrays were analyzed by immunohistochemistry [18].